Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Author index

Page Path
HOME > Browse > Author index
Search
Ah-Ram Kim  (Kim AR) 1 Article
Basic Research
Article image
Inhibition of Ceramide Accumulation in Podocytes by Myriocin Prevents Diabetic Nephropathy
Chang-Yun Woo, Ji Yeon Baek, Ah-Ram Kim, Chung Hwan Hong, Ji Eun Yoon, Hyoun Sik Kim, Hyun Ju Yoo, Tae-Sik Park, Ranjan Kc, Ki-Up Lee, Eun Hee Koh
Diabetes Metab J. 2020;44(4):581-591.   Published online November 4, 2019
DOI: https://doi.org/10.4093/dmj.2019.0063
  • 7,365 View
  • 178 Download
  • 33 Web of Science
  • 35 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Ceramides are associated with metabolic complications including diabetic nephropathy in patients with diabetes. Recent studies have reported that podocytes play a pivotal role in the progression of diabetic nephropathy. Also, mitochondrial dysfunction is known to be an early event in podocyte injury. Thus, we tested the hypothesis that ceramide accumulation in podocytes induces mitochondrial damage through reactive oxygen species (ROS) production in patients with diabetic nephropathy.

Methods

We used Otsuka Long Evans Tokushima Fatty (OLETF) rats and high-fat diet (HFD)-fed mice. We fed the animals either a control- or a myriocin-containing diet to evaluate the effects of the ceramide. Also, we assessed the effects of ceramide on intracellular ROS generation and on podocyte autophagy in cultured podocytes.

Results

OLETF rats and HFD-fed mice showed albuminuria, histologic features of diabetic nephropathy, and podocyte injury, whereas myriocin treatment effectively treated these abnormalities. Cultured podocytes exposed to agents predicted to be risk factors (high glucose, high free fatty acid, and angiotensin II in combination [GFA]) showed an increase in ceramide accumulation and ROS generation in podocyte mitochondria. Pretreatment with myriocin reversed GFA-induced mitochondrial ROS generation and prevented cell death. Myriocin-pretreated cells were protected from GFA-induced disruption of mitochondrial integrity.

Conclusion

We showed that mitochondrial ceramide accumulation may result in podocyte damage through ROS production. Therefore, this signaling pathway could become a pharmacological target to abate the development of diabetic kidney disease.

Citations

Citations to this article as recorded by  
  • Interplay of lipid metabolism and inflammation in podocyte injury
    Zilv Luo, Zhaowei Chen, Jijia Hu, Guohua Ding
    Metabolism.2024; 150: 155718.     CrossRef
  • Associations of plasma sphingolipids with measures of insulin sensitivity, β-cell function, and incident diabetes in Japanese Americans
    Ji Cheol Bae, Pandora L. Wander, Rozenn N. Lemaitre, Amanda M. Fretts, Colleen M. Sitlani, Hai H. Bui, Melissa K. Thomas, Donna Leonetti, Wilfred Y. Fujimoto, Edward J. Boyko, Kristina M. Utzschneider
    Nutrition, Metabolism and Cardiovascular Diseases.2024; 34(3): 633.     CrossRef
  • A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer’s disease, and their co-morbidities
    Yun Pan, Jieying Li, Panjie Lin, Lihua Wan, Yiqian Qu, Lingyong Cao, Lei Wang
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Ceramides and mitochondrial homeostasis
    Song Ding, Guorui Li, Tinglv Fu, Tianyu Zhang, Xiao Lu, Ning Li, Qing Geng
    Cellular Signalling.2024; 117: 111099.     CrossRef
  • The Influence of Soy Isoflavones and Soy Isoflavones with Inulin on Kidney Morphology, Fatty Acids, and Associated Parameters in Rats with and without Induced Diabetes Type 2
    Kamila Misiakiewicz-Has, Dominika Maciejewska-Markiewicz, Dagmara Szypulska-Koziarska, Agnieszka Kolasa, Barbara Wiszniewska
    International Journal of Molecular Sciences.2024; 25(10): 5418.     CrossRef
  • Deletion of IRE1α in podocytes exacerbates diabetic nephropathy in mice
    Andrey V. Cybulsky, Joan Papillon, Julie Guillemette, José R. Navarro-Betancourt, Chen-Fang Chung, Takao Iwawaki, I. George Fantus
    Scientific Reports.2024;[Epub]     CrossRef
  • Roles of Mitochondrial Dysfunction in Diabetic Kidney Disease: New Perspectives from Mechanism to Therapy
    Yichen Yang, Jiahui Liu, Qiling Shi, Buyu Guo, Hanbing Jia, Yuxuan Yang, Songbo Fu
    Biomolecules.2024; 14(6): 733.     CrossRef
  • Lipidomic study of kidney in a mouse model with urine flow obstruction
    Divyavani Gowda, Md. Abdul Masum, Siddabasave Gowda B. Gowda, Chandra Shekhar, Md. Zahir Uddin Rubel, Shunnosuke Kira, Osamu Ichii, Yasuhiro Kon, Hitoshi Chiba, Shu-Ping Hui
    Scientific Reports.2024;[Epub]     CrossRef
  • Sphingolipids and Chronic Kidney Disease
    Zrinka Šakić, Armin Atić, Slavica Potočki, Nikolina Bašić-Jukić
    Journal of Clinical Medicine.2024; 13(17): 5050.     CrossRef
  • A review on the novel biomarkers of systemic lupus erythematosus discovered via metabolomic profiling
    Yinghong Liu, Xiaojuan Yang
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Reduced sphingolipid biosynthesis modulates proteostasis networks to enhance longevity
    Nathaniel L. Hepowit, Eric Blalock, Sangderk Lee, Kimberly M. Bretland, Jason A. MacGurn, Robert C. Dickson
    Aging.2023; 15(2): 472.     CrossRef
  • Protective effect of natural products in the metabolic-associated kidney diseases via regulating mitochondrial dysfunction
    Peng Liu, Yao Chen, Jing Xiao, Wenhui Zhu, Xiaoming Yan, Ming Chen
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • BCAA insufficiency leads to premature ovarian insufficiency via ceramide‐induced elevation of ROS
    Xiao Guo, Yuemeng Zhu, Lu Guo, Yiwen Qi, Xiaocheng Liu, Jinhui Wang, Jiangtao Zhang, Linlin Cui, Yueyang Shi, Qichu Wang, Cenxi Liu, Guangxing Lu, Yilian Liu, Tao Li, Shangyu Hong, Yingying Qin, Xuelian Xiong, Hao Wu, Lin Huang, He Huang, Chao Gu, Bin Li,
    EMBO Molecular Medicine.2023;[Epub]     CrossRef
  • Chinese herbal medicine and its active compounds in attenuating renal injury via regulating autophagy in diabetic kidney disease
    Peng Liu, Wenhui Zhu, Yang Wang, Guijie Ma, Hailing Zhao, Ping Li
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Integrated gas chromatography‐mass spectrometry and ultra‐high‐performance liquid chromatography‐mass spectrometry renal metabolomics and lipidomics deciphered the metabolic regulation mechanism of Gushudan on kidney‐yang‐deficiency‐syndrome rats
    Qing Lu, Jing Zhang, Ling Xin, Yanwei Lou, Feng Qin, Longshan Zhao, Zhili Xiong
    Journal of Separation Science.2023;[Epub]     CrossRef
  • Advances in the pharmacological study of Chinese herbal medicine to alleviate diabetic nephropathy by improving mitochondrial oxidative stress
    Ming Chen, Yao Chen, Wenhui Zhu, Xiaoming Yan, Jing Xiao, Peiqing Zhang, Peng Liu, Ping Li
    Biomedicine & Pharmacotherapy.2023; 165: 115088.     CrossRef
  • Rodent models to study type 1 and type 2 diabetes induced human diabetic nephropathy
    Amit Talukdar, Mandira Basumatary
    Molecular Biology Reports.2023; 50(9): 7759.     CrossRef
  • Art2 mediates selective endocytosis of methionine transporters during adaptation to sphingolipid depletion
    Nathaniel L. Hepowit, Bradley Moon, Adam C. Ebert, Robert C. Dickson, Jason A. MacGurn
    Journal of Cell Science.2023;[Epub]     CrossRef
  • Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
    Alla Mitrofanova, Sandra Merscher, Alessia Fornoni
    Nature Reviews Nephrology.2023; 19(10): 629.     CrossRef
  • Research progress of autophagy in pathogenesis of diabetes nephropathy
    Shengnan Zeng, Ying Li
    Diabetic Nephropathy.2023; 3(3): 51.     CrossRef
  • Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease
    Judy Baek, Chenchen He, Farsad Afshinnia, George Michailidis, Subramaniam Pennathur
    Nature Reviews Nephrology.2022; 18(1): 38.     CrossRef
  • Podocyte Bioenergetics in the Development of Diabetic Nephropathy: The Role of Mitochondria
    Irena Audzeyenka, Agnieszka Bierżyńska, Abigail C Lay
    Endocrinology.2022;[Epub]     CrossRef
  • Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
    Xiaodie Mu, Min Yang, Peiyao Ling, Aihua Wu, Hua Zhou, Jingting Jiang
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 247.     CrossRef
  • Research Progress on Natural Products’ Therapeutic Effects on Atrial Fibrillation by Regulating Ion Channels
    Jinshan He, Sicong Li, Yumeng Ding, Yujia Tong, Xuebin Li, Simona Saponara
    Cardiovascular Therapeutics.2022; 2022: 1.     CrossRef
  • Mechanisms of podocyte injury and implications for diabetic nephropathy
    Federica Barutta, Stefania Bellini, Gabriella Gruden
    Clinical Science.2022; 136(7): 493.     CrossRef
  • A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury
    Norishi Ueda
    International Journal of Molecular Sciences.2022; 23(7): 4010.     CrossRef
  • Implications of Sphingolipid Metabolites in Kidney Diseases
    Shamroop kumar Mallela, Sandra Merscher, Alessia Fornoni
    International Journal of Molecular Sciences.2022; 23(8): 4244.     CrossRef
  • Role of ceramides in the pathogenesis of diabetes mellitus and its complications
    Nawajes Mandal, Richard Grambergs, Koushik Mondal, Sandip K. Basu, Faiza Tahia, Sam Dagogo-Jack
    Journal of Diabetes and its Complications.2021; 35(2): 107734.     CrossRef
  • Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease
    Rebekah J. Nicholson, Marcus G. Pezzolesi, Scott A. Summers
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Enhancing lifespan of budding yeast by pharmacological lowering of amino acid pools
    Nathaniel L. Hepowit, Jessica K. A. Macedo, Lyndsay E. A. Young, Ke Liu, Ramon C. Sun, Jason A. MacGurn, Robert C. Dickson
    Aging.2021; 13(6): 7846.     CrossRef
  • New insights into renal lipid dysmetabolism in diabetic kidney disease
    Alla Mitrofanova, George Burke, Sandra Merscher, Alessia Fornoni
    World Journal of Diabetes.2021; 12(5): 524.     CrossRef
  • Excessively Enlarged Mitochondria in the Kidneys of Diabetic Nephropathy
    Kiyoung Kim, Eun-Young Lee
    Antioxidants.2021; 10(5): 741.     CrossRef
  • Mechanistic insights into the role of serum-glucocorticoid kinase 1 in diabetic nephropathy: A systematic review
    Saba Noor, Taj Mohammad, Gulam M. Ashraf, Joviana Farhat, Anwar L. Bilgrami, Mathew Suji Eapen, Sukhwinder Singh Sohal, Dharmendra Kumar Yadav, Md Imtaiyaz Hassan
    International Journal of Biological Macromolecules.2021; 193: 562.     CrossRef
  • The Updates of Podocyte Lipid Metabolism in Proteinuric Kidney Disease
    Yu Sun, Sijia Cui, Yunfeng Hou, Fan Yi
    Kidney Diseases.2021; 7(6): 438.     CrossRef
  • Saturated fatty acids induce insulin resistance in podocytes through inhibition of IRS1 via activation of both IKKβ and mTORC1
    Benoit Denhez, Marina Rousseau, Crysta Spino, David-Alexandre Dancosst, Marie-Ève Dumas, Andréanne Guay, Farah Lizotte, Pedro Geraldes
    Scientific Reports.2020;[Epub]     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP